The identification and assay of 2-methyl-5-nitroimidazole in pigs treated with dimetridazole.
G Carignan, K Carrier, S Sved
Index: Food Addit. Contam. 8(4) , 467-75, (1991)
Full Text: HTML
Abstract
An unidentified metabolite of dimetridazole (DMZ), found in pig plasma, muscle and kidney, was shown by chromatography and spectroscopy to be 2-methyl-5-nitroimidazole (2-MNI), resulting from N-demethylation of DMZ. This route of degradation competes with the oxidation pathway previously described. The concentration of 2-MNI in the plasma of pig fed medicated diet (DMZ 0.0125%) ranged from 29 to 83 ppb, 2 hours after the morning meal, similar to DMZ, but lower than that of the major metabolite, 2-hydroxymethyl-1-methyl-5-nitroimidazole (HMMNI). Its elimination profile in plasma was biphasic, similar to those of HMMNI and DMZ. Early and terminal half lives were 2.6 and 9.1 h respectively. None of the metabolites could be detected in any of the tissues studied 49 hours after withdrawal.
Related Compounds
Related Articles:
On the hydrolytic behavior of tinidazole, metronidazole, and ornidazole.
2003-04-01
[J. Pharm. Sci. 92(4) , 739-46, (2003)]
1987-05-01
[Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 51(5) , 797-809, (1987)]
[Synthesis and antibacterial activity of ciprofloxacin derivatives].
2005-02-01
[Yao Xue Xue Bao 40(2) , 132-5, (2005)]
2003-04-01
[Yao Xue Xue Bao 38(4) , 260-3, (2003)]
1999-09-01
[Hua Xi Yi Ke Da Xue Xue Bao 30(3) , 345-6, (1999)]